The Delivery of mRNA Vaccines for Therapeutics

被引:40
|
作者
Nitika [1 ,2 ]
Wei, Jiao [1 ,2 ]
Hui, Ai-Min [1 ,2 ]
机构
[1] Fosun Pharma USA Inc, Boston, MA 02421 USA
[2] Shanghai Fosun Pharmaceut Ind Dev Co Ltd, Shanghai 200233, Peoples R China
来源
LIFE-BASEL | 2022年 / 12卷 / 08期
关键词
mRNA; vaccines; delivery route; formulations; delivery methods; immunity; RESPIRATORY SYNCYTIAL VIRUS; DENDRITIC CELL VACCINES; LIPID NANOPARTICLES; IMMUNE-RESPONSES; INFLUENZA-VIRUS; PROTECTIVE EFFICACY; CATIONIC LIPIDS; RABIES VACCINE; CANCER-THERAPY; IMMUNOGENICITY;
D O I
10.3390/life12081254
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier play an important role. mRNA vaccines can be delivered using lipid nanoparticles, polymers, peptides or naked mRNA. The vaccine efficacy is influenced by the appropriate delivery materials, formulation methods and selection of a proper administration route. In addition, co-delivery of several mRNAs could also be beneficial and enhance immunity against various variants of an infectious pathogen or several pathogens altogether. Here, we review the recent progress in the delivery methods, modes of delivery and patentable mRNA vaccine technologies.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Development and Delivery Systems of mRNA Vaccines
    Liu, Tiancai
    Liang, Yongjun
    Huang, Liping
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [22] Nanomaterial Delivery Systems for mRNA Vaccines
    Buschmann, Michael D.
    Carrasco, Manuel J.
    Alishetty, Suman
    Paige, Mikell
    Alameh, Mohamad Gabriel
    Weissman, Drew
    VACCINES, 2021, 9 (01) : 1 - 30
  • [23] Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
    Trepotec, Zeljka
    Lichtenegger, Eva
    Plank, Christian
    Aneja, Manish K.
    Rudolph, Carsten
    MOLECULAR THERAPY, 2019, 27 (04) : 794 - 802
  • [24] Gene editing therapeutics based on mRNA delivery
    Popovitz, Juliana
    Sharma, Rohit
    Hoshyar, Reyhane
    Kim, Beob Soo
    Murthy, Niren
    Lee, Kunwoo
    ADVANCED DRUG DELIVERY REVIEWS, 2023, 200
  • [25] M cell-targeted delivery of vaccines and therapeutics
    KuoLee, Rhonda
    Chen, Wangxue
    EXPERT OPINION ON DRUG DELIVERY, 2008, 5 (06) : 693 - 702
  • [26] An overview of rational design of mRNA-based therapeutics and vaccines
    To, Kenneth K. W.
    Cho, William C. S.
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (11) : 1307 - 1317
  • [27] Designer polypeptides for cancer therapeutics and controlled mRNA delivery
    Hammond, Paula
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [28] Multifunctional nanoparticles for drug and mRNA delivery in cancer therapeutics
    Honglawan, Apiradee
    Ni, Houping
    Weissman, Drew
    Yang, Shu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [29] Production of vaccines and therapeutics in transgenic plants for oral delivery.
    Welter, LM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U37 - U37
  • [30] Synthetic DNA Templates Accelerate Development of mRNA Based Therapeutics and Vaccines
    Walker, Amy
    Picher, Angel
    Lanckriet, Heikki
    MOLECULAR THERAPY, 2023, 31 (04) : 620 - 620